The Recall Desk
HighFDA (Devices)·Z-2095-2018·Announced 2018-06-13

Tosoh ST-AIA PACK HGH Assay Recalled Due to Strensiq Interference

Tosoh Bioscience Inc is recalling ST-AIA PACK HGH assays because Asfotase Alfa (Strensiq) interferes with the tests, potentially causing inaccurate results.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves potential diagnostic errors (falsely increased or decreased results) which poses a risk of harm to patients, fitting the 'High' severity criteria for risk-of-harm products.

Plain-English summary

Tosoh Bioscience Inc is recalling 752 units of ST-AIA PACK HGH (Part Number: 025266) assays. The recall is due to interference from the drug Asfotase Alfa (Strensiq), which can cause falsely increased or decreased immunoassay test results depending on the specific assay.

The affected products were distributed worldwide, including the United States, Canada, Mexico, and various countries in South and Central America. All lot codes are included in this recall.

Healthcare providers and laboratories should stop using the affected assays and contact Tosoh Bioscience Inc for further instructions regarding the recall and potential replacement or refund.

The recalled product

Product
ST-AIA PACK HGH; Part Number: 025266 Assay, Metabolic
Affected units
752

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • All Lot Codes

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 35 recalled by Tosoh Bioscience Inc under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 35 products in this recall →